Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose This study analyzed the outcomes of patients with resected extrahepatic bile duct cancer (EHBDC) in order to clarify the role of adjuvant treatments in these patients. Materials and Methods A total of 336 patients with EHBDC who underwent curative resection between 2001 and 2010 were analyzed retrospectively. The treatment types were as follows: surgery alone (n=168), surgery with chemotherapy (CTx, n=90), surgery with radiotherapy (RT) alone (n=29), and surgery with chemoradiotherapy (CRT, n=49). Results The median follow-up period was 63 months. The 5-year rates of locoregional failure-free survival (LRFFS), distant metastasis-free survival (DMFS), progression-free survival (PFS), and overall survival (OS) for all patients were 56.5%, 59.7%, 36.6%, and 42.0%, respectively. In multivariate analysis, surgery with RT and CRT was a significant prognostic factor for LRFFS, and surgery with CTx was a significant prognostic factor for DMFS, and surgery with CTx, RT, and CRT was a significant prognostic factor for PFS (p < 0.05). Surgery with CTx and CRT showed association with superior OS (p < 0.05), and surgery with RT had marginal significance (p=0.078). In multivariate analysis of the R1 resection patients, surgery with CRT showed significant association with OS (p < 0.05). Conclusion Adjuvant RT and CTx may be helpful in improving clinical outcomes of patients with resected EHBDC who have a high risk of disease recurrence, particularly R1 resection patients. Conduct of additional prospective, larger-scale studies will be required in order to confirm the benefit of adjuvant RT and CTx in these patients.
Abstract
Purpose This study analyzed the outcomes of patients with resected extrahepatic bile duct cancer (EHBDC) in order to clarify the role of adjuvant treatments in these patients. Materials and Methods A total of 336 patients with EHBDC who underwent curative resection between 2001 and 2010 were analyzed retrospectively. The treatment types were as follows: surgery alone (n=168), surgery with chemotherapy (CTx, n=90), surgery with radiotherapy (RT) alone (n=29), and surgery with chemoradiotherapy (CRT, n=49). Results The median follow-up period was 63 months. The 5-year rates of locoregional failure-free survival (LRFFS), distant metastasis-free survival (DMFS), progression-free survival (PFS), and overall survival (OS) for all patients were 56.5%, 59.7%, 36.6%, and 42.0%, respectively. In multivariate analysis, surgery with RT and CRT was a significant prognostic factor for LRFFS, and surgery with CTx was a significant prognostic factor for DMFS, and surgery with CTx, RT, and CRT was a significant prognostic factor for PFS (p < 0.05). Surgery with CTx and CRT showed association with superior OS (p < 0.05), and surgery with RT had marginal significance (p=0.078). In multivariate analysis of the R1 resection patients, surgery with CRT showed significant association with OS (p < 0.05). Conclusion Adjuvant RT and CTx may be helpful in improving clinical outcomes of patients with resected EHBDC who have a high risk of disease recurrence, particularly R1 resection patients. Conduct of additional prospective, larger-scale studies will be required in order to confirm the benefit of adjuvant RT and CTx in these patients.
참고문헌 (19)
- Khan SA, "Cholangiocarcinoma", Lancet, 366, pp.1303~1314 (2005)
- Murakami Y, "Perineural invasion in extrahepatic cholangiocarcinoma : prognostic impact and treatment strategies", J Gastrointest Surg, 17, pp.1429~1439 (2013)
- Gwak HK, "Extrahepatic bile duct cancers : surgery alone versus surgery plus postoperative radiation therapy", Int J Radiat Oncol Biol Phys, 78, pp.194~198 (2010)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010", Cancer Research and Treatment, 45(1), pp.1~14 (2013), 대한암학회[DOI]
- Todoroki T, "Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma", Int J Radiat Oncol Biol Phys, 46, pp.581~587 (2000)
- Todoroki T, "Treatment strategy for patients with middle and lower third bile duct cancer", Br J Surg, 88, pp.364~370 (2001)
- Borghero Y, "Extrahepatic bile duct adenocarcinoma : patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone", Ann Surg Oncol, 15, pp.3147~3156 (2008)
- Kim TH, "Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer", Int J Radiat Oncol Biol Phys, 81, pp.853~859 (2011)
- Fuller CD, "Multimodality therapy for locoregional extrahepatic cholangiocarcinoma : a population-based analysis", Cancer, 115, pp.5175~5183 (2009)
- Sagawa N, "Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma", Surg Today, 35, pp.548~552 (2005)
- Vern-Gross TZ, "Survival outcomes in resected extrahepatic cholangiocarcinoma : effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis", Int J Radiat Oncol Biol Phys, 81, pp.189~198 (2011)
- 임정호, "Postoperative radiotherapy dose correlates with locoregional control in patients with extra-hepatic bile duct cancer", Radiation oncology journal, 32(1), pp.7~13 (2014), 대한방사선종양학회
- Jarnagin WR, "Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma : implications for adjuvant therapeutic strategies", Cancer, 98, pp.1689~1700 (2003)
- Choi SB, "The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection", J Surg Oncol, 99, pp.335~342 (2009)
- Tae Ryool Koo, "Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy", Radiation oncology journal, 32(2), pp.63~69 (2014), 대한방사선종양학회
- Park JH, "Postoperative chemoradiotherapy for extrahepatic bile duct cancer", Int J Radiat Oncol Biol Phys, 79, pp.696~704 (2011)
- Kim K, "Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience", Am J Clin Oncol, 35, pp.136~140 (2012)
- Takada T, "Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma", Cancer, 95, pp.1685~1695 (2002)
- Lim KH, "Adjuvant concurrent chemoradiation therapy(CCRT)alone versus CCRT followed by adjuvant chemotherapy : which is better in patients with radically resected extrahepatic biliary tract cancer? : a non-randomized, single center study", BMC Cancer, 9, pp.345~ (2009)